A court has ruled that media reports accusing well-known orthopaedic surgeon Dr Munjed Al Muderis of unethical and profit-driven promotion of an experimental procedure were substantially true, tossing his defamation suit against Fairfax and its owner Nine.
The High Court has rejected Novartis’ plea that it overturn a ruling that found an extension of the term of the patent for its heart drug Entresto was invalidly granted.
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.
Mayne Pharma has denied US drug maker Cosette’s claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.
Genomic sequencing company Oxford Nanopore Technologies has sued MGI Australia alleging infringement of four patents covering nanopore technology.
A class action against aged care provider Bupa faced tough questions by a judge on Monday, who grilled counsel over the case’s theory of loss. And the answers — rather than reassuring her — raised the spectre of a summary judgment fight.
A court has heard US drug maker Cosette may amend its case to accuse Adelaide’s Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.
Mayne Pharma has said it may seek to shut out US drug maker Cosette’s expert evidence in proceedings over the purported termination of their $672 million merger.
A discrimination class action has been filed on behalf of single women and same-sex couples designated “socially infertile” and denied Medicare rebates for IVF.
Flu vaccine maker Seqirus has successfully opposed Moderna’s proposed patent for a mRNA vaccine, but an IP Australia delegate said the problems with the patent can be overcome by amendments.